Arkolith/Insider Trading/PHAT/Form 4

Basta Steven L

President and CEO, DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed Apr 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 3, 2025Grant(A)360K—$0360K
Apr 3, 2025Grant(A)1.1M—$01.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-050621) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML